- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Sparsentan has not yet been approved for marketing in Chinese Mainland. Patients need to obtain the drug through overseas channels, but they ne...
Sparsentan has not been listed in Chinese Mainland and has not been included in the national medical insurance reimbursement. If patients need ...
The standard method of taking elacestrant is once daily oral administration of 345mg (four tablets of 86mg each), which should be swallowed who...
The standard usage of elacestrant is once daily oral administration of 345mg, which should be taken as a whole tablet until disease progression...
Lomitamide, as a specific drug for the treatment of homozygous familial hypercholesterolemia (HoFH), has not been listed in Chinese Mainland an...
Lomitapide, as a microsomal triglyceride transfer protein (MTP) inhibitor, has significant therapeutic effects on homozygous familial hyperchol...
Fumarate propofol tenofovir tablets (Vemlidy) are a novel nucleotide reverse transcriptase inhibitor mainly used for the treatment of chronic h...
Fumarate propofol tenofovir tablets (Vemlidy) are a novel antiviral drug primarily used for the treatment of chronic hepatitis B virus infectio...
Fumarate propofol tenofovir tablets (Vemlidy) are a nucleotide analogue reverse transcriptase inhibitor mainly used for the treatment of chroni...
Propenofovir fumarate tablet (Vemlidy) is a highly effective anti hepatitis B virus drug, which is mainly used for the antiviral treatment of c...
